Therapeutic Respiratory Devices Market By Product Type (Nebulizers, Positive Airway Pressure (PAP) Devices, Oxygen Concentrators, Ventilators, Inhalers), By End-User Industry (Hospitals & Clinics, Home Healthcare, Ambulatory Surgical Centers (ASCs), Long-term Care Facilities), By Indication (Chronic Obstructive Pulmonary Disease (COPD), Asthma, Sleep Apnea, Respiratory Infections, Cystic Fibrosis), By Technology (Electric, Battery-operated, Manual), and By Region; Global Insights & Forecast (2023 – 2030)

As per Intent Market Research, the Therapeutic Respiratory Devices Market was valued at USD 17.6 Billion in 2024-e and will surpass USD 35.9 Billion by 2030; growing at a CAGR of 12.6% during 2025-2030.

The therapeutic respiratory devices market is expanding rapidly, driven by the increasing prevalence of respiratory diseases, the rise of aging populations, and advancements in medical technology. These devices are designed to aid in the management and treatment of respiratory conditions such as asthma, chronic obstructive pulmonary disease (COPD), and sleep apnea. They are critical tools in the healthcare sector, helping to improve patients' quality of life by providing essential therapy for breathing-related ailments. The growing demand for home-based healthcare solutions is further propelling market growth, as patients seek convenient, portable, and effective treatment options. With continued innovation in device functionality, this market is poised for significant advancements in the coming years.

Nebulizers Segment Is Largest Owing to Broad Application in Respiratory Care

Among the various product types in the therapeutic respiratory devices market, nebulizers hold the largest share. Nebulizers are widely used in the treatment of asthma, COPD, and other respiratory disorders due to their ability to deliver medication directly to the lungs in the form of a mist. These devices are particularly effective for patients who have difficulty using inhalers, such as young children, the elderly, or those with severe respiratory conditions. Nebulizers are increasingly used in both hospital settings and home healthcare, where their ease of use and effectiveness make them a preferred option.

The growing prevalence of asthma and COPD worldwide is a significant factor driving the demand for nebulizers. In addition, the development of portable, battery-powered nebulizers has made them even more accessible for home use. As a result, the nebulizer segment continues to lead the market, with ongoing innovations in design and efficiency aimed at improving patient comfort and treatment outcomes.

Battery-Operated Technology Is Fastest Growing Due to Portability and Convenience

Battery-operated therapeutic respiratory devices are the fastest growing in the market, fueled by the increasing demand for portable, user-friendly devices. These devices offer patients the flexibility to manage their respiratory conditions at home or on the go, making them especially popular among individuals with chronic respiratory diseases like asthma and COPD. Battery-operated devices, including portable nebulizers, positive airway pressure (PAP) devices, and oxygen concentrators, have become essential tools for enhancing patient mobility while ensuring consistent and effective therapy.

As patient preferences shift toward convenience and ease of use, battery-operated devices are expected to continue their rapid growth. These devices are particularly important for patients who require continuous respiratory support but want to maintain a degree of independence. The improvements in battery technology, which allow for longer usage times and quicker charging, further bolster the adoption of these devices, making them a key driver of market expansion.

Home Healthcare Industry Is Largest End-User Due to Rising Demand for At-Home Treatment

The home healthcare sector is the largest end-user of therapeutic respiratory devices, reflecting the growing trend of managing chronic conditions outside of traditional healthcare facilities. As more patients opt for home-based care to avoid hospital visits and reduce healthcare costs, the demand for portable and easy-to-use respiratory devices has surged. Devices such as nebulizers, PAP devices, and oxygen concentrators are in high demand among individuals with conditions like asthma, COPD, and sleep apnea, all of which require ongoing management and therapy.

This segment's growth is also supported by the increasing aging population, which is more prone to respiratory issues and is increasingly preferring home healthcare options. The home healthcare industry's growth is not only driven by the convenience it offers patients but also by the cost-effectiveness for healthcare systems and insurance companies. With advancements in telemedicine and remote patient monitoring, home healthcare is expected to continue to lead the market in terms of demand for respiratory devices.

North America Region Leads the Therapeutic Respiratory Devices Market Due to Strong Healthcare Infrastructure

North America is the largest region in the therapeutic respiratory devices market, driven by a combination of factors such as advanced healthcare infrastructure, high awareness of respiratory diseases, and a strong demand for innovative medical devices. The U.S., in particular, is home to a large population of individuals suffering from chronic respiratory diseases, leading to a high demand for effective therapeutic respiratory devices. Additionally, the presence of leading companies in the region, along with favorable reimbursement policies for respiratory treatments, further strengthens the market position of North America.

The region's rapid adoption of new healthcare technologies, including advanced therapeutic respiratory devices, coupled with ongoing research and development in the medical device sector, ensures that North America will maintain its dominant market share. The high level of healthcare spending and the increasing shift toward home healthcare models contribute to continued growth in the North American market for therapeutic respiratory devices.

Leading Companies and Competitive Landscape

The therapeutic respiratory devices market is highly competitive, with several leading companies dominating the industry. Prominent players include Philips Healthcare, ResMed, Medtronic, Invacare Corporation, and Fisher & Paykel Healthcare, among others. These companies are continuously innovating to develop more efficient, user-friendly, and portable devices that meet the growing demand for respiratory care. They focus on advancing technology, improving device comfort, and expanding their product offerings to cater to a wide range of respiratory conditions.

The competitive landscape is marked by strategic collaborations, mergers, acquisitions, and partnerships aimed at expanding product portfolios and improving market reach. As the market continues to evolve, companies are increasingly focusing on the development of battery-operated and portable devices to capture a larger share of the home healthcare segment. Additionally, the growing focus on patient-centered care, digital health, and remote monitoring technologies is expected to drive future innovations in therapeutic respiratory devices, enhancing the competitive dynamics of the market

List of Leading Companies:

• Philips Healthcare
• ResMed
• Medtronic
• Invacare Corporation
• Fisher & Paykel Healthcare
• Drive DeVilbiss Healthcare
• GE Healthcare
• CareFusion Corporation
• Smiths Medical
• Vyaire Medical
• Nihon Kohden
• Becton Dickinson and Company
• Omron Healthcare
• Hamilton Medical
• Teleflex Inc.

Recent Developments:

• In January 2025, Philips Healthcare launched a new portable oxygen concentrator designed for both hospital and home use. This device features improved battery life and more compact design, enhancing patient comfort.
• ResMed expanded its product portfolio with the introduction of a new line of PAP devices in March 2025, offering enhanced comfort and smart connectivity features to assist with sleep apnea management.
• Medtronic announced in December 2024 that it had received FDA approval for its new ventilator, which integrates AI technology to better monitor and adjust settings based on patient needs during mechanical ventilation.
• In February 2025, Invacare Corporation acquired a leading home healthcare provider, significantly enhancing its presence in the North American market for therapeutic respiratory devices.
• Fisher & Paykel Healthcare unveiled a new high-flow nasal cannula device in April 2025, designed to improve oxygen delivery and patient comfort, especially in acute respiratory distress situations.

Report Scope: